≡ Menu ≡ Menu

Zantac Liver Angiosarcoma Lawsuit: Were You or a Loved One Diagnosed With Liver Angiosarcoma or Hemangiocarcinoma After Taking Zantac?

Zantac Angiosarcoma lawsuit cases settlement claims Ranitidine hemangiocarcinoma

If you or a loved one were diagnosed with Liver Angiosarcoma or Hemangiocarcinoma of the liver after taking Zantac (Ranitidine), you may be entitled to recover compensation from a Zantac liver angiosarcoma lawsuit case or settlement claim.

A team of heartburn drug injury lawyers and class action attorneys is investigating potential lawsuit and settlement cases of individuals who were diagnosed with angiosarcoma of the liver or hemangiocarcinoma of the liver after taking Zantac (Ranitidine).

Liver angiosarcoma (or hemangiocarcinoma) is an aggressive form of liver cancer that forms in the lining of blood vessels and lymph vessels of the liver. Liver angiosarcoma is a rare form of liver cancer, comprising about 1-2 percent of all liver cancer cases. Liver angiosarcoma is most commonly seen in older males. The prognosis of liver angiosarcoma is considered very poor, as many patients are not diagnosed until the cancer has spread throughout the body.

Zantac Liver Angiosarcoma Lawsuit Cases

Zantac angiosarcoma lawsuit and settlement cases potentially being investigated include claims of individuals who took recalled Zantac and suffered serious injuries, side-effects or complications including, among others:

  • Liver Angiosarcoma
  • Angiosarcoma of the liver
  • Hemangiocarcinoma of the liver
  • Hepatic angiosarcoma
  • Kupffer cell sarcoma

If you or someone you love took Zantac and have suffered from angiosarcoma of the liver or Hemangiocarcinoma of the liver, you may be entitled to compensation from a Zantac liver angiosarcoma lawsuit or settlement. Contact a drug injury lawyer to request a free case review.

*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.

**The listing of a company (e.g., Sandoz, Pfizer, GlaxoSmithKline, Sanofi, Apotex, Perrigo, Lannett or Novitium) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.

***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.

Fill out the form for a free attorney review.